适应不良
失代偿
心脏病学
内科学
心力衰竭
肺动脉高压
肌肉肥大
医学
右心室肥大
病理生理学
缺氧(环境)
右心室衰竭
氧气
化学
精神科
有机化学
作者
Marta Oknińska,Karolina Zajda,Zuzanna Zambrowska,Małgorzata Grzanka,Aleksandra Paterek,Urszula Mackiewicz,Cezary Szczylik,Marcin Kurzyna,Agnieszka Piekiełko‐Witkowska,Adam Torbicki,Claudine Kiéda,Michał Mączewski
标识
DOI:10.1016/j.jchf.2023.03.010
摘要
Right ventricular (RV) function and eventually failure determine outcome in patients with pulmonary arterial hypertension (PAH). Initially, RV responds to an increased load caused by PAH with adaptive hypertrophy; however, eventually RV failure ensues. Unfortunately, it is unclear what causes the transition from compensated RV hypertrophy to decompensated RV failure. Moreover, at present, there are no therapies for RV failure; those for left ventricular (LV) failure are ineffective, and no therapies specifically targeting RV are available. Thus there is a clear need for understanding the biology of RV failure and differences in physiology and pathophysiology between RV and LV that can ultimately lead to development of such therapies. In this paper, we discuss RV adaptation and maladaptation in PAH, with a particular focus of oxygen delivery and hypoxia as the principal drivers of RV hypertrophy and failure, and attempt to pinpoint potential sites for therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI